RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Qian-Jin Zhang to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Qian-Jin Zhang has written about Drug Evaluation, Preclinical.
Qian-Jin Zhang
Connection Strength
0.216
Drug Evaluation, Preclinical
  1. Shao Y, Zhang QC. Targeting RNA structures in diseases with small molecules. Essays Biochem. 2020 12 07; 64(6):955-966.
    View in: PubMed
    Score: 0.184
  2. Zhong Q, Zhang C, Zhang Q, Miele L, Zheng S, Wang G. Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status. BMC Cancer. 2015 Sep 09; 15:625.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support